ENDOLOGIX INC - NOTE 3.250%11/0

Historical Holders from Q4 2015 to Q1 2020

Type / Class
Debt / NOTE 3.250%11/0
All holders as of 31 Mar 2020
Q1 2020
Total 13F principal, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ENDOLOGIX INC - NOTE 3.250%11/0

Period Principal Value Change Price Investors
2020 Q1 0 $0 -$3,760,000 0
2019 Q4 4,000,000 $3,760,000 $0.94 1
2019 Q3 4,000,000 $3,835,000 -$1,305,000 $0.9588 1
2019 Q2 10,995,000 $5,140,000 -$55,068,000 $0.614 2
2019 Q1 84,350,000 $58,611,000 $0.6846 5
2018 Q4 84,350,000 $59,258,000 +$4,146 $0.7143 5
2018 Q3 88,405,000 $61,302,000 -$39,400,489 $0.6909 7
2018 Q2 124,755,000 $115,608,000 +$141,885 $0.919 9
2018 Q1 124,605,000 $107,446,000 -$169,745 $0.86 9
2017 Q4 124,775,000 $112,802,000 +$39,246 $0.9078 10
2017 Q3 124,775,000 $107,870,000 -$771,842 $0.8647 10
2017 Q2 126,300,000 $107,237,000 -$35,229 $0.8557 13
2017 Q1 126,400,000 $124,886,000 -$6,860,374 $0.9882 12
2016 Q4 134,275,000 $117,403,000 -$14,695,983 $0.8738 13
2016 Q3 125,392,000 $166,421,000 -$1,057,429 $1.32 16
2016 Q2 126,192,000 $164,640,000 +$21,095,098 $1.3 14
2016 Q1 124,250,000 $119,870,000 +$20,749,527 $0.9606 14
2015 Q4 101,105,000 $109,779,190 +$97,288,000 $1.09 14